{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:01:39Z","timestamp":1791216099001,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.03.110","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T11:30:45Z","timestamp":1462015845000},"page":"2962-2966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Status of vaccine research and development of vaccines for Staphylococcus aureus"],"prefix":"10.1016","volume":"34","author":[{"given":"Birgitte K.","family":"Giersing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana S.","family":"Dastgheyb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasee","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.110_bib0200","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0205","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0210","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.110_bib0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajic.2014.12.024","article-title":"Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort","volume":"43","author":"Farley","year":"2015","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.vaccine.2016.03.110_bib0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1473-3099(09)70022-2","article-title":"Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia","volume":"9","author":"Nickerson","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.110_bib0225","doi-asserted-by":"crossref","first-page":"e6512","DOI":"10.1371\/journal.pone.0006512","article-title":"Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country","volume":"4","author":"Nickerson","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(10)61458-4","article-title":"Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis","volume":"377","author":"Allegranzi","year":"2011","journal-title":"Lancet (Lond, Engl)"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0235","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0240","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/425019","article-title":"Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA","volume":"190","author":"Carleton","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajic.2005.06.006","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections","volume":"33","author":"Kourbatova","year":"2005","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2015.08.015","article-title":"Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus strains isolated from hospital effluents","author":"Mandal","year":"2015","journal-title":"Am J Infect Control"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.110_bib0255","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-3156.1997.d01-213.x","article-title":"Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam","volume":"2","author":"Van Duong","year":"1997","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0260","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/jac\/dkr278","article-title":"Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?","volume":"66","author":"Mostofsky","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0265","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1016\/j.vaccine.2009.06.055","article-title":"Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States","volume":"27","author":"Lucero","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0270","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinte.165.15.1756","article-title":"The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database","volume":"165","author":"Noskin","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0275","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/522186","article-title":"National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998\u20132003)","volume":"45","author":"Noskin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.110_bib0280","doi-asserted-by":"crossref","first-page":"e61319","DOI":"10.1371\/journal.pone.0061319","article-title":"Within-host evolution of Staphylococcus aureus during asymptomatic carriage","volume":"8","author":"Golubchik","year":"2013","journal-title":"PLOS ONE"},{"issue":"14","key":"10.1016\/j.vaccine.2016.03.110_bib0285","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1002\/pmic.201100134","article-title":"Surface shaving as a versatile tool to profile global interactions between human serum proteins and the Staphylococcus aureus cell surface","volume":"11","author":"Dreisbach","year":"2011","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.vaccine.2016.03.110_bib0290","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2217\/imt.11.84","article-title":"Immunotherapeutic approaches against Staphylococcus aureus","volume":"3","author":"Verkaik","year":"2011","journal-title":"Immunotherapy"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.03.110_bib0295","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ijantimicag.2008.06.009","article-title":"Vaccination and passive immunisation against Staphylococcus aureus","volume":"32","author":"Schaffer","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.vaccine.2016.03.110_bib0300","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.vaccine.2003.11.034","article-title":"Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials","volume":"22","author":"Fattom","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0305","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/hv.34414","article-title":"Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0310","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2016.03.110_bib0315","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/1469-0691.12570","article-title":"Where does a Staphylococcus aureus vaccine stand?","volume":"20","author":"Fowler","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2016.03.110_bib0320","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.4161\/hv.25182","article-title":"Will there ever be a universal Staphylococcus aureus vaccine?","volume":"9","author":"Pier","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"25","key":"10.1016\/j.vaccine.2016.03.110_bib0325","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2013.04.002","article-title":"Vaccine review: Staphyloccocus aureus vaccines: problems and prospects","volume":"31","author":"Jansen","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.110_bib0330","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14760584.2013.840091","article-title":"Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage","volume":"12","author":"Botelho-Nevers","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0335","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/cir828","article-title":"Progress toward a Staphylococcus aureus vaccine","volume":"54","author":"Daum","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.110_bib0340","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrmicro3308","article-title":"Models matter: the search for an effective Staphylococcus aureus vaccine","volume":"12","author":"Salgado-Pab\u00f3n","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.110_bib0345","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4161\/hv.34407","article-title":"Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors","volume":"10","author":"McNeely","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.110_bib0350","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.4161\/hv.21872","article-title":"Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors","volume":"8","author":"Anderson","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jim.2014.04.007","article-title":"Mouse models for infectious diseases caused by Staphylococcus aureus","volume":"410","author":"Kim","year":"2014","journal-title":"J Immunol Methods"},{"issue":"10","key":"10.1016\/j.vaccine.2016.03.110_bib0360","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/infdis\/jit800","article-title":"Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli","volume":"209","author":"Wacker","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.110_bib0365","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/21645515.2015.1011021","article-title":"Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: results of a randomized phase I trial","volume":"11","author":"Levy","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.110_bib0370","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1128\/IAI.00258-15","article-title":"Four-component Staphylococcus aureus vaccine 4C-staph enhances Fc\u03b3 receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice","volume":"83","author":"Torre","year":"2015","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2016.03.110_bib0375","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1128\/IAI.00009-15","article-title":"Generation of a novel Staphylococcus aureus ghost vaccine and examination of its immunogenicity against virulent challenge in rats","volume":"83","author":"Vinod","year":"2015","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2016.03.110_bib0380","doi-asserted-by":"crossref","first-page":"e0137874","DOI":"10.1371\/journal.pone.0137874","article-title":"Antibodies to S. aureus LukS-PV Attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs","volume":"10","author":"Adhikari","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2016.03.110_bib0385","unstructured":"http:\/\/www.aridispharma.com\/ar301.html."},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.110_bib0390","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1128\/AAC.00510-15","article-title":"MEDI4893* promotes survival and extends the antibiotic treatment window in a Staphylococcus aureus immunocompromised pneumonia model","volume":"59","author":"Hua","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T13:22:12Z","timestamp":1536758532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16301694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":39,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16301694"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.110","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of vaccine research and development of vaccines for Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}